Monthly Archives: January 2008

I-Team: Pharmacies Not Required To Report Mix-Ups (WBAL-TV Baltimore)

Most of the time, pharmacies probably gets prescription orders correct, but some WBAL TV 11 News viewers say that their pharmacies have gotten it dangerously wrong.

8 Ways to Fight Food Hangovers (Newsweek)

For anyone who’s still feeling the effects of those rich holiday meals, here’s our guide to getting your digestive system back in order.

The Cost of Childhood Obesity (Newsweek)

Why the costs could be ‘catastrophic’ if we don’t stop the epidemic now.

McKesson quarterly net profit falls (Reuters via Yahoo! News)

Pharmaceutical wholesaler McKesson Corp reported on Thursday that its quarterly profit fell 17 percent as results were hit by charges and lower profit margins on generic drugs.

McKesson Reports Fiscal 2008 Third-Quarter Results (Centre Daily Times)

McKesson Corporation (NYSE:MCK) today reported that revenues for the third fiscal quarter ended December 31, 2007, were $26.5 billion compared to $23.1 billion a year ago. Third-quarter earnings per diluted share from continuing operations was 68 cents compared to 79 cents per diluted share a year ago. Third-quarter results include approximately two cents per share dilution from Oncology …

McKesson Reports Fiscal 2008 Third-Quarter Results (Business Wire via Yahoo! Finance)

SAN FRANCISCO—-McKesson Corporation today reported that revenues for the third fiscal quarter ended December 31, 2007, were $26.5 billion compared to $23.1 billion a year ago. Third-quarter earnings per diluted share from continuing operations was 68 cents compared to 79 cents per diluted share a year ago.

Wyeth grows profit, but generics pose threat (BizJournals)

Drug maker Wyeth said profit rose in the fourth quarter, though the company expects a weaker 2008 on competition from generic treatments. (WYE)

Learn about Recent Gastrointestinal Drug Discoveries (Centre Daily Times)

Research and Markets (http://www.researchandmarkets.com/reports/c81393) has announced the addition of “Gastrointestinal Drug Discoveries” to their offering.

Axcan Pharma Reports Solid Start to Fiscal 2008, With Revenue of $92.9 Million in the First Quarter (Marketwire via Yahoo! Finance)

Axcan Pharma Inc.(NASDAQ: AXCA) today announced financial results for the first quarter of fiscal 2008. All amounts are in U.S. dollars.

Learn about Recent Gastrointestinal Drug Discoveries (Business Wire via Yahoo! Finance)

DUBLIN, Ireland—-Research and Markets has announced the addition of “Gastrointestinal Drug Discoveries” to their offering.

Wednesday’s Winners & Losers: Yahoo! (TheStreet.com)

Shares fall 8.5% after the company offers a soft revenue outlook for 2008.

Wednesday’s Health Winners & Losers (TheStreet.com)

Merck falls.

Prasco, ESI Lederle ink deal to distribute Protonix generic (Cincinnati Business Courier)

A distribution agreement between Prasco Laboratories and a division of Wyeth Pharmaceuticals will allow the Cincinnati-based company to market a generic version of the acid reflux drug Protonix being launched by Wyeth. (WYE)

Jocy’s recovery aided by support of community (The Monroe Evening News)

Recovery has been full of progress and setbacks for Bedford Junior High School student, but the family remains optimistic through prayers and community support.

FDA Approves EMEND(R) (fosaprepitant dimeglumine) for Injection, Merck’s New Intravenous Therapy, for Use in … (Business Wire via Yahoo! Finance)

WHITEHOUSE STATION, N.J.—-Merck & Co., Inc. today announced that the U.S. Food and Drug Administration has approved EMEND® for Injection, a new intravenous therapy for the prevention of chemotherapy-induced nausea and vomiting .

FDA Approves EMEND(R) (fosaprepitant dimeglumine) for Injection, Merck’s New Intravenous Therapy, for Use in … (Business Wire via Yahoo! Finance)

WHITEHOUSE STATION, N.J.—-Merck & Co., Inc. today announced that the U.S. Food and Drug Administration has approved EMEND® for Injection, a new intravenous therapy for the prevention of chemotherapy-induced nausea and vomiting .

Cranberry extracts show promise against gullet cancer (Nutraingredients.com)

A proanthocyanidins-rich cranberry extract was found to inhibit the growth and spread of human oesophageal adenocarcinoma (a cancer in glandular tissue) cells, report the researchers from Ohio State University and the Blueberry and Cranberry Research Center at Rutgers University.

$4 million awarded in wrongful death suit after 45-minute deliberation (Charleston Daily Mail)

A Wetzel County jury deliberated for about 45 minutes before deciding a New Martinsville doctor should pay $4 million to the surviving children of a woman who died from what one witness called an “intra-abdominal catastrophe.”

Axia3 Debuts Nationally: All Natural, Safe Treatment for Heartburn (PRWeb)

Axia3 (www.Axia3.com), the fast acting, all natural treatment for heartburn, is now conveniently available nationwide at all GNC stores as well as Drugstore.com, numerous Whole Foods locations throughout Southern California and other select retailers. The brand, which is a proud member of the Natural Products Association, comes in a colorful package with 30 individual packets. Both GNC and …

Ask Dr. Weil: There’s much to learn about ‘hippotherapy’ (Arizona Daily Star)

QI just heard about a program that uses horses to help handicapped kids. What can you tell me about this type of therapy?